title: [Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C].
authors.affiliation: Infektionskliniken I 73, Huddinge sjukhus.
authors.forename: O
authors.initials: O
authors.lastname: Weiland
authors.forename: G
authors.initials: G
authors.lastname: Norkrans
authors.forename: A
authors.initials: A
authors.lastname: Frydén
authors.forename: J H
authors.initials: JH
authors.lastname: Braconier
mesh_terms: D002908:Chronic Disease; D000075202:Contraindications; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D011379:Prognosis; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D016898:Interferon-alpha; D012254:Ribavirin
vernacular_title: Hälften svarar på interferonbehandling. Kombinationsterapi alternativ vid kronisk hepatit C.